D. Stewart

Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16

Michael Crump, Stefan Glück, Dongsheng Tu et al. · Journal of Clinical Oncology · 2007 · 54 citations · Full text

Phase II Study of Troxacitabine (BCH-4556) in Patients With Advanced and/or Metastatic Renal Cell Carcinoma: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Carol Townsley, K. Chi, D. Scott Ernst et al. · Journal of Clinical Oncology · 2003 · 37 citations

Activity of lenalidomide in a phase II trial for T-cell lymphoma: Report on the first 24 cases

Greg Dueck, Neil Chua, Angeli Prasad et al. · Journal of Clinical Oncology · 2009 · 27 citations

Immunology, Immunotherapy, Hematological Malignancy +16

A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study

Stefan Glück, Michael Crump, D. Stewart et al. · European Journal of Cancer · 2001 · 22 citations

National Cancer Institute, Metastatic Breast Cancer, Breast Oncology +8

A case of an accessory testicular artery.

Marios Loukas, D. Stewart · PubMed · 2004 · 22 citations

Left Renal Artery, Gross Anatomy, Andrology +13